XOMAO
XOMA Royalty Corporation
Price Chart
Latest Quote
$25.41
Current Price| Previous Close | $25.39 |
| Open | $25.30 |
| Day High | $25.46 |
| Day Low | $25.30 |
| Volume | 2,453 |
Stock Information
| Quarterly Dividend / Yield | $2.09 / 8.24% |
| Total Debt | $133.89M |
| Cash Equivalents | $46.71M |
| Revenue | $47.11M |
| Net Income | $9.86M |
| Sector | Healthcare |
| Industry | Biotechnology |
| P/E Ratio | 25.38 |
| EPS (TTM) | $1.00 |
| Exchange | NGM |
📊 Custom Metrics & Score
Score: 16/42| Debt to Equity | 1.46 |
| Debt to Earnings | -6.12 |
| Current Ratio | 5.15 |
| Quick Ratio | 5.01 |
| Avg Revenue Growth | -18.30% |
| Profit Margin | -135.23% |
| Return on Equity | -16.87% |
| Avg FCF Growth | 65.06% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $25.41 | 2,453 |
| 2026-01-30 | $25.39 | 2,600 |
| 2026-01-29 | $25.40 | 3,000 |
| 2026-01-28 | $25.30 | 2,100 |
| 2026-01-27 | $25.40 | 2,400 |
| 2026-01-26 | $25.34 | 1,600 |
| 2026-01-23 | $25.35 | 1,300 |
| 2026-01-22 | $25.33 | 8,700 |
| 2026-01-21 | $25.40 | 3,200 |
| 2026-01-20 | $25.35 | 2,500 |
| 2026-01-16 | $25.32 | 1,600 |
| 2026-01-15 | $25.35 | 3,800 |
| 2026-01-14 | $25.41 | 6,100 |
| 2026-01-13 | $25.29 | 1,100 |
| 2026-01-12 | $25.36 | 2,300 |
| 2026-01-09 | $25.34 | 4,000 |
| 2026-01-08 | $25.33 | 1,300 |
| 2026-01-07 | $25.35 | 5,100 |
| 2026-01-06 | $25.35 | 3,100 |
| 2026-01-05 | $25.30 | 6,700 |
| 2026-01-02 | $nan | 0 |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
📰 Latest News
Institutional owners may take dramatic actions as XOMA Royalty Corporation's (NASDAQ:XOMA) recent 12% drop adds to one-year losses
Simply Wall St. • 2026-01-18T12:01:34Z
XOMA Royalty (NASDAQ:XOMA) shareholders have earned a 13% CAGR over the last three years
Simply Wall St. • 2025-12-21T12:47:49Z
Huge Insider Buying in MGM and Salesforce
24/7 Wall St. • 2025-12-12T14:45:59Z
Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug
Investor's Business Daily • 2025-12-11T23:41:24Z
XOMA Royalty's (NASDAQ:XOMA) Earnings Aren't As Good As They Appear
Simply Wall St. • 2025-11-19T10:44:16Z
Earnings Beat: XOMA Royalty Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Simply Wall St. • 2025-11-15T12:41:36Z
A Note On XOMA Royalty Corporation's (NASDAQ:XOMA) ROE and Debt To Equity
Simply Wall St. • 2025-11-14T11:12:45Z
Why Xoma, a drug royalty firm, is hunting biotech ‘zombies’
BioPharma Dive • 2025-09-23T06:00:00Z
XOMA Royalty Corporation (NASDAQ:XOMA) Could Be Less Than A Year Away From Profitability
Simply Wall St. • 2025-09-22T13:32:18Z
Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect?
Zacks • 2025-09-19T13:55:01Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | $10,220,000 | $4,758,000 | $6,027,000 | $38,160,000 |
| Operating Revenue | $10,220,000 | $4,758,000 | $6,027,000 | $38,160,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $13,840,000 | $569,000 | $0 | $461,000 |
| Total Expenses | $19,292,000 | $26,646,000 | $23,441,000 | $20,631,000 |
| Other Income Expense | $3,433,000 | $-18,374,000 | $295,000 | $-1,179,000 |
| Other Non Operating Income Expenses | $297,000 | $75,000 | $40,000 | $5,000 |
| Net Non Operating Interest Income Expense | $-13,840,000 | $-569,000 | $0 | $-461,000 |
| Interest Expense Non Operating | $13,840,000 | $569,000 | $0 | $461,000 |
| Operating Expense | $19,292,000 | $26,646,000 | $23,441,000 | $20,631,000 |
| Other Operating Expenses | $-18,267,000 | - | - | - |
| General And Administrative Expense | $34,478,000 | $25,606,000 | $23,191,000 | $20,460,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Net Interest Income | $-13,840,000 | $-569,000 | $0 | $-461,000 |
| Normalized Income | $-16,047,560 | $-22,382,000 | $-17,359,000 | $16,970,160 |
| Net Income From Continuing And Discontinued Operation | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Total Operating Income As Reported | $-39,976,000 | $-41,848,000 | $-17,414,000 | $17,529,000 |
| Net Income Common Stockholders | $-19,293,000 | $-46,303,000 | $-22,576,000 | $7,787,000 |
| Net Income | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Net Income Including Noncontrolling Interests | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Net Income Continuous Operations | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Pretax Income | $-19,479,000 | $-40,831,000 | $-17,119,000 | $15,889,000 |
| Special Income Charges | $-11,588,000 | $-19,960,000 | $0 | $-300,000 |
| Operating Income | $-9,072,000 | $-21,888,000 | $-17,414,000 | $17,529,000 |
| Depreciation Amortization Depletion Income Statement | $206,000 | $897,000 | $97,000 | $0 |
| Depreciation And Amortization In Income Statement | $206,000 | $897,000 | $97,000 | $0 |
| Amortization Of Intangibles Income Statement | $206,000 | $897,000 | $97,000 | $0 |
| Average Dilution Earnings | - | - | $0 | $181,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $909,440 | $0 | $0 | $-11,840 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,559,000 | $-20,913,000 | $-17,270,000 | $17,541,000 |
| Total Unusual Items | $3,136,000 | $-18,449,000 | $255,000 | $-1,184,000 |
| Total Unusual Items Excluding Goodwill | $3,136,000 | $-18,449,000 | $255,000 | $-1,184,000 |
| Reconciled Depreciation | $216,000 | $900,000 | $104,000 | $7,000 |
| EBITDA (Bullshit earnings) | $-5,423,000 | $-39,362,000 | $-17,015,000 | $16,357,000 |
| EBIT | $-5,639,000 | $-40,262,000 | $-17,119,000 | $16,350,000 |
| Diluted NI Availto Com Stockholders | $-19,293,000 | $-46,303,000 | $-22,576,000 | $7,968,000 |
| Preferred Stock Dividends | $5,472,000 | $5,472,000 | $5,472,000 | $4,560,000 |
| Tax Provision | $-5,658,000 | $0 | $-15,000 | $91,000 |
| Write Off | $30,904,000 | $15,828,000 | $0 | - |
| Restructuring And Mergern Acquisition | $-19,316,000 | $0 | $0 | - |
| Gain On Sale Of Security | $14,724,000 | $1,511,000 | $255,000 | $-884,000 |
| Amortization | $206,000 | $897,000 | $97,000 | $0 |
| Research And Development | $2,875,000 | $143,000 | $153,000 | $171,000 |
| Selling General And Administration | $34,478,000 | $25,606,000 | $23,191,000 | $20,460,000 |
| Other Gand A | $34,478,000 | $25,606,000 | $23,191,000 | $20,460,000 |
| Other Special Charges | - | $4,132,000 | - | $300,000 |
| Impairment Of Capital Assets | - | $15,828,000 | $0 | - |
| Otherunder Preferred Stock Dividend | - | - | $0 | $3,451,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $56,012,000 | $88,721,000 | $108,864,000 | $141,876,000 |
| Total Assets | $221,277,000 | $234,301,000 | $140,382,000 | $166,562,000 |
| Total Non Current Assets | $95,673,000 | $64,988,000 | $79,129,000 | $69,589,000 |
| Other Non Current Assets | $69,413,000 | $64,585,000 | $63,943,000 | $69,376,000 |
| Goodwill And Other Intangible Assets | $25,909,000 | $0 | $15,150,000 | $0 |
| Current Assets | $125,604,000 | $169,313,000 | $61,253,000 | $96,973,000 |
| Other Current Assets | $2,076,000 | $483,000 | $725,000 | $613,000 |
| Restricted Cash | $1,330,000 | $160,000 | $0 | $2,049,000 |
| Receivables | $17,015,000 | $15,219,000 | $2,367,000 | $209,000 |
| Other Receivables | $15,176,000 | $14,215,000 | $2,366,000 | - |
| Accounts Receivable | $1,839,000 | $1,004,000 | $1,000 | $209,000 |
| Cash Cash Equivalents And Short Term Investments | $105,183,000 | $153,451,000 | $58,161,000 | $94,102,000 |
| Cash And Cash Equivalents | $101,654,000 | $153,290,000 | $57,826,000 | $93,328,000 |
| Non Current Accounts Receivable | - | $57,952,000 | $63,683,000 | $69,075,000 |
| Investmentin Financial Assets | - | - | - | $0 |
| Prepaid Assets | - | - | - | $613,000 |
| Taxes Receivable | - | - | - | $0 |
| Cash Financial | - | - | - | $93,328,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $16,615,000 | - | - | - |
| Total Debt | $119,198,000 | $124,450,000 | $34,000 | $229,000 |
| Long Term Debt And Capital Lease Obligation | $107,358,000 | $118,853,000 | $0 | $34,000 |
| Long Term Debt | $106,875,000 | $118,518,000 | - | - |
| Current Debt And Capital Lease Obligation | $11,840,000 | $5,597,000 | $34,000 | $195,000 |
| Current Debt | $11,394,000 | $5,543,000 | - | - |
| Other Current Borrowings | $11,394,000 | $5,543,000 | - | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $139,356,000 | $145,580,000 | $16,368,000 | $24,686,000 |
| Total Non Current Liabilities Net Minority Interest | $114,982,000 | $126,081,000 | $9,550,000 | $11,719,000 |
| Other Non Current Liabilities | $3,214,000 | - | - | - |
| Non Current Deferred Liabilities | $4,410,000 | $7,228,000 | $9,550,000 | $11,685,000 |
| Current Liabilities | $24,374,000 | $19,499,000 | $6,818,000 | $12,967,000 |
| Other Current Liabilities | $3,000,000 | $7,000,000 | $75,000 | $8,075,000 |
| Current Deferred Liabilities | $1,361,000 | $2,113,000 | $1,899,000 | $1,641,000 |
| Payables And Accrued Expenses | $6,618,000 | $3,586,000 | $4,248,000 | $3,001,000 |
| Interest Payable | $3,039,000 | $535,000 | - | - |
| Payables | $2,701,000 | $2,021,000 | $1,892,000 | $2,531,000 |
| Dividends Payable | $1,368,000 | $1,368,000 | $1,368,000 | $1,368,000 |
| Total Tax Payable | $280,000 | $0 | $0 | $91,000 |
| Income Tax Payable | $280,000 | $0 | $0 | $91,000 |
| Accounts Payable | $1,053,000 | $653,000 | $524,000 | $1,072,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $81,872,000 | $88,672,000 | $123,965,000 | $141,827,000 |
| Preferred Stock Equity | $49,000 | $49,000 | $49,000 | $49,000 |
| Total Equity Gross Minority Interest | $81,921,000 | $88,721,000 | $124,014,000 | $141,876,000 |
| Stockholders Equity | $81,921,000 | $88,721,000 | $124,014,000 | $141,876,000 |
| Gains Losses Not Affecting Retained Earnings | $73,000 | $0 | - | - |
| Other Equity Adjustments | $73,000 | - | - | - |
| Retained Earnings | $-1,237,057,000 | $-1,223,223,000 | $-1,182,392,000 | $-1,165,288,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Preferred Shares Number | $2,584,000 | $2,584,000 | $2,584,000 | $2,584,000 |
| Ordinary Shares Number | $11,952,377 | $11,495,492 | $11,454,025 | $11,315,263 |
| Share Issued | $11,952,377 | $11,495,492 | $11,454,025 | $11,315,263 |
| Tangible Book Value | $55,963,000 | $88,672,000 | $108,815,000 | $141,827,000 |
| Invested Capital | $200,141,000 | $212,733,000 | $123,965,000 | $141,827,000 |
| Working Capital | $101,230,000 | $149,814,000 | $54,435,000 | $84,006,000 |
| Capital Lease Obligations | $929,000 | $389,000 | $34,000 | $229,000 |
| Total Capitalization | $188,796,000 | $207,239,000 | $124,014,000 | $141,876,000 |
| Additional Paid In Capital | $1,318,766,000 | $1,311,809,000 | $1,306,271,000 | $1,307,030,000 |
| Capital Stock | $139,000 | $135,000 | $135,000 | $134,000 |
| Common Stock | $90,000 | $86,000 | $86,000 | $85,000 |
| Preferred Stock | $49,000 | $49,000 | $49,000 | $49,000 |
| Non Current Deferred Revenue | $4,410,000 | $7,228,000 | $9,550,000 | $11,685,000 |
| Long Term Capital Lease Obligation | $483,000 | $335,000 | $0 | $34,000 |
| Current Deferred Revenue | $1,361,000 | $2,113,000 | $1,899,000 | $1,641,000 |
| Current Capital Lease Obligation | $446,000 | $54,000 | $34,000 | $195,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,555,000 | $1,203,000 | $562,000 | $55,000 |
| Current Accrued Expenses | $3,917,000 | $1,565,000 | $2,356,000 | $470,000 |
| Net PPE | $351,000 | $403,000 | $36,000 | $213,000 |
| Gross PPE | $351,000 | $403,000 | $36,000 | $213,000 |
| Other Properties | $351,000 | $403,000 | $36,000 | $213,000 |
| Other Short Term Investments | $3,529,000 | $161,000 | $335,000 | $774,000 |
| Treasury Shares Number | - | $0 | - | - |
| Investments And Advances | - | - | - | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-13,768,000 | $-18,175,000 | $-28,126,000 | $-3,822,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-13,748,000 | $-18,158,000 | $-12,879,000 | $22,678,000 |
| Cash Flow From Continuing Operating Activities | $-13,748,000 | $-18,158,000 | $-12,879,000 | $22,678,000 |
| Operating Gains Losses | $118,000 | $123,000 | $85,000 | $390,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-20,000 | $-17,000 | $-15,247,000 | $-26,500,000 |
| Investing Cash Flow | $-28,259,000 | $-711,000 | $-20,221,000 | $-26,500,000 |
| Cash Flow From Continuing Investing Activities | $-28,259,000 | $-711,000 | $-20,221,000 | $-26,500,000 |
| Net Other Investing Changes | $-23,752,000 | $-694,000 | $-4,974,000 | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-13,000 | $0 | - | - |
| Financing Cash Flow | $-11,127,000 | $120,593,000 | $-4,451,000 | $12,835,000 |
| Cash Flow From Continuing Financing Activities | $-11,127,000 | $120,593,000 | $-4,451,000 | $12,835,000 |
| Net Other Financing Charges | $-3,954,000 | $-4,401,000 | $-1,398,000 | $-21,000,000 |
| Cash Dividends Paid | $-5,472,000 | $-5,472,000 | $-5,472,000 | $-3,499,000 |
| Preferred Stock Dividend Paid | $-5,472,000 | $-5,472,000 | $-5,472,000 | $-3,499,000 |
| Net Common Stock Issuance | $-13,000 | $0 | - | - |
| Issuance Of Capital Stock | - | - | $0 | $40,000,000 |
| Net Preferred Stock Issuance | - | - | $0 | $40,000,000 |
| Preferred Stock Issuance | - | - | $0 | $40,000,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-6,902,000 | $0 | $0 | $-4,250,000 |
| Issuance Of Debt | $0 | $130,000,000 | $0 | - |
| Interest Paid Supplemental Data | $9,985,000 | $0 | $0 | $311,000 |
| Income Tax Paid Supplemental Data | $9,985,000 | $0 | $76,000 | $0 |
| End Cash Position | $106,416,000 | $159,550,000 | $57,826,000 | $95,377,000 |
| Beginning Cash Position | $159,550,000 | $57,826,000 | $95,377,000 | $86,364,000 |
| Changes In Cash | $-53,134,000 | $101,724,000 | $-37,551,000 | $9,013,000 |
| Proceeds From Stock Option Exercised | $5,214,000 | $466,000 | $2,419,000 | $1,584,000 |
| Common Stock Payments | $-13,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-6,902,000 | $130,000,000 | $0 | $-4,250,000 |
| Net Long Term Debt Issuance | $-6,902,000 | $130,000,000 | $0 | $-4,250,000 |
| Long Term Debt Payments | $-6,902,000 | $0 | $0 | $-4,250,000 |
| Long Term Debt Issuance | $0 | $130,000,000 | $0 | - |
| Net Investment Purchase And Sale | $-3,237,000 | $0 | - | - |
| Purchase Of Investment | $-3,237,000 | $0 | - | - |
| Net Business Purchase And Sale | $-1,250,000 | $0 | - | - |
| Sale Of Business | $18,926,000 | $0 | - | - |
| Purchase Of Business | $-20,176,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-20,000 | $-17,000 | $0 | $0 |
| Purchase Of PPE | $-20,000 | $-17,000 | $0 | $0 |
| Change In Working Capital | $-2,789,000 | $-3,529,000 | $-181,000 | $-886,000 |
| Change In Other Working Capital | $-3,570,000 | $-2,108,000 | $-1,877,000 | $-1,642,000 |
| Change In Other Current Liabilities | $-284,000 | $-114,000 | $-195,000 | $-1,511,000 |
| Change In Payables And Accrued Expense | $1,598,000 | $-523,000 | $1,754,000 | $856,000 |
| Change In Payable | $1,598,000 | $-523,000 | $1,754,000 | $856,000 |
| Change In Account Payable | $1,598,000 | $-523,000 | $1,845,000 | $765,000 |
| Change In Prepaid Assets | $302,000 | $219,000 | $-71,000 | $-169,000 |
| Change In Receivables | $-835,000 | $-1,003,000 | $208,000 | $1,580,000 |
| Other Non Cash Items | $-2,068,000 | $1,653,000 | $170,000 | $255,000 |
| Stock Based Compensation | $10,312,000 | $9,099,000 | $3,608,000 | $6,195,000 |
| Unrealized Gain Loss On Investment Securities | $-58,000 | $174,000 | $439,000 | $919,000 |
| Asset Impairment Charge | $0 | $14,253,000 | $0 | - |
| Deferred Tax | $-5,658,000 | $0 | - | - |
| Deferred Income Tax | $-5,658,000 | $0 | - | - |
| Depreciation Amortization Depletion | $216,000 | $900,000 | $104,000 | $7,000 |
| Depreciation And Amortization | $216,000 | $900,000 | $104,000 | $7,000 |
| Amortization Cash Flow | $206,000 | $897,000 | $97,000 | $0 |
| Amortization Of Intangibles | $206,000 | $897,000 | $97,000 | $0 |
| Depreciation | $10,000 | $3,000 | $7,000 | $7,000 |
| Pension And Employee Benefit Expense | $118,000 | $123,000 | $85,000 | $90,000 |
| Gain Loss On Sale Of Business | $-19,316,000 | $0 | - | - |
| Net Income From Continuing Operations | $-13,821,000 | $-40,831,000 | $-17,104,000 | $15,798,000 |
| Net Intangibles Purchase And Sale | - | $0 | $-15,247,000 | $-26,500,000 |
| Purchase Of Intangibles | - | $0 | $-15,247,000 | $-26,500,000 |
| Change In Tax Payable | - | $0 | $-91,000 | $91,000 |
| Change In Income Tax Payable | - | $0 | $-91,000 | $91,000 |
| Sale Of Intangibles | - | - | $3,026,000 | $0 |
| Changes In Account Receivables | - | - | $208,000 | $54,000 |